Literature DB >> 21617692

NLRX1/NOD5 deficiency does not affect MAVS signalling.

M Rebsamen, J Vazquez, A Tardivel, G Guarda, J Curran, J Tschopp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21617692      PMCID： PMC3172102          DOI： 10.1038/cdd.2011.64

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  8 in total

Review 1.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections.

Authors:  Himanshu Kumar; Surya Pandey; Jian Zou; Yutaro Kumagai; Ken Takahashi; Shizuo Akira; Taro Kawai
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

3.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

4.  The specific and essential role of MAVS in antiviral innate immune responses.

Authors:  Qinmiao Sun; Lijun Sun; Hong-Hsing Liu; Xiang Chen; Rashu B Seth; James Forman; Zhijian J Chen
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

5.  Enhancement of reactive oxygen species production and chlamydial infection by the mitochondrial Nod-like family member NLRX1.

Authors:  Ali A Abdul-Sater; Najwane Saïd-Sadier; Verissa M Lam; Bhavni Singh; Matthew A Pettengill; Fraser Soares; Ivan Tattoli; Simone Lipinski; Stephen E Girardin; Philip Rosenstiel; David M Ojcius
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

6.  NLRX1 is a regulator of mitochondrial antiviral immunity.

Authors:  Chris B Moore; Daniel T Bergstralh; Joseph A Duncan; Yu Lei; Thomas E Morrison; Albert G Zimmermann; Mary A Accavitti-Loper; Victoria J Madden; Lijun Sun; Zhengmao Ye; John D Lich; Mark T Heise; Zhijian Chen; Jenny P-Y Ting
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

7.  An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix.

Authors:  Damien Arnoult; Fraser Soares; Ivan Tattoli; Céline Castanier; Dana J Philpott; Stephen E Girardin
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

8.  NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production.

Authors:  Ivan Tattoli; Leticia A Carneiro; Muguette Jéhanno; Joao G Magalhaes; Youmin Shu; Dana J Philpott; Damien Arnoult; Stephen E Girardin
Journal:  EMBO Rep       Date:  2008-01-25       Impact factor: 8.807
  8 in total
  45 in total

1.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

Review 3.  Mechanisms of MAVS regulation at the mitochondrial membrane.

Authors:  Jana L Jacobs; Carolyn B Coyne
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

4.  NLRX1 has a tail to tell.

Authors:  Tsan Sam Xiao; Jenny P-Y Ting
Journal:  Immunity       Date:  2012-03-23       Impact factor: 31.745

Review 5.  Regulation where autophagy intersects the inflammasome.

Authors:  Mary A Rodgers; James W Bowman; Qiming Liang; Jae U Jung
Journal:  Antioxid Redox Signal       Date:  2013-07-31       Impact factor: 8.401

6.  Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.

Authors:  Yanzheng Tong; Jun Cui; Qingtian Li; Jia Zou; Helen Y Wang; Rong-Fu Wang
Journal:  Cell Res       Date:  2012-04-03       Impact factor: 25.617

7.  NOD so fast: NLRX1 puts the brake on inflammation.

Authors:  Kislay Parvatiyar; Genhong Cheng
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

8.  NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Authors:  Joanna Jaworska; François Coulombe; Jeffrey Downey; Fanny Tzelepis; Karim Shalaby; Ivan Tattoli; Julie Berube; Simon Rousseau; James G Martin; Stephen E Girardin; Jonathan A McCullers; Maziar Divangahi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

9.  The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Authors:  Aaron M Tocker; Emily Durocher; Kimberly D Jacob; Kate E Trieschman; Suzanna M Talento; Alma A Rechnitzer; David M Roberts; Beckley K Davis
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 10.  Alarmins, inflammasomes and immunity.

Authors:  Najwane Saïd-Sadier; David M Ojcius
Journal:  Biomed J       Date:  2012 Nov-Dec       Impact factor: 4.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.